EVE Health Group Limited (AU:EVE) has released an update.
EVE Health Group Limited has announced the sale of its subsidiary Jenbrook’s ‘Robyndale’ property in Northern NSW to CB Landholdings Pty Ltd, a renewable energy firm, for $2.125 million. The deal includes a 5% upfront deposit and is contingent on due diligence and regulatory approval within set timeframes. Proceeds from the sale are earmarked for the expansion of Meluka Australia and potential acquisitions to bolster EVE’s health and wellness portfolio.
For further insights into AU:EVE stock, check out TipRanks’ Stock Analysis page.